CTI BioPharma
CTIC
#5631
Rank
S$1.52 B
Marketcap
S$11.58
Share price
0.00%
Change (1 day)
24.92%
Change (1 year)

CTI BioPharma (CTIC) - Total debt

Total debt on the balance sheet as of March 2023 : S$62.28 Million

According to CTI BioPharma 's latest financial reports the company's total debt is S$62.28 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

CTI BioPharma - Total debt on balance sheet (from 1997 to 2023)

Total debt by year

Year Total debt Change
2022-12-31S$66.97 M-2.01%
2021-12-31S$68.34 M883.12%
2020-12-31S$6.95 M-57.94%
2019-12-31S$16.52 M-14.07%
2018-12-31S$19.23 M2.58%
2017-12-31S$18.75 M-32.73%
2016-12-31S$27.87 M-65.2%
2015-12-31S$80.1 M248.87%
2014-12-31S$22.96 M36.19%
2013-12-31S$16.85 M
2012-12-31N/A
2010-12-31S$36.36 M-60.34%
2009-12-31S$91.69 M-56.09%
2008-12-31S$0.20 B-2.13%
2007-12-31S$0.21 B-16.53%
2006-12-31S$0.25 B-34.28%
2005-12-31S$0.38 B21.33%
2004-12-31S$0.32 B-1.64%
2003-12-31S$0.32 B60.09%
2002-12-31S$0.20 B-38.4%
2001-12-31S$0.33 B7350.66%
2000-12-31S$4.43 M-29.87%
1999-12-31S$6.32 M-24.86%
1998-12-31S$8.42 M31.42%
1997-12-31S$6.4 M43.06%
1996-12-31S$4.47 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
S$45.06 B 72,250.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$54.14 B 86,827.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$69.53 B 111,541.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$12.45 B 19,902.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$51.47 M-17.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$60.04 B 96,308.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$21.77 B 34,860.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel